References
- Friedman DI. Papilledema. In: Miller NR, Newman NJ, eds. Walsh & Hoyt’s clinical neuro-ophthalmology. 6th ed. Philadelphia, US: Lippincott Williams & Wilkins; 2005:238–250
- Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1956;6:791–803
- Sorensen PS, Thomsen C, Gjerris F, Henriksen O. Brain water accumulation in pseudotumor cerebri demonstrated by MR-imaging of brain water self-diffusion. Acta Neurochir Suppl (Wien) 1990;51:363–365
- Ahlskog JE, O'Neill BP. Pseudotumor cerebri. Ann Intern Med 1982;97:249–256
- Leonard G, Wright M, Quinn M. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer 2005;5:116–125
- O'Dea D, Handy C, Wexler A. Ocular changes with oxaliplatin. Clin J Oncol Nurs 2006;10:227–229
- Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 2005;5:38–46
- Tang RA, Kellaway J, Young SE. Ophthalmic manifestations of systemic cancer. Oncology 1991;5:59–66
- Wilkes G, Barton-Burke M. Oncology nursing drug handbook. Jones & Bartlett Learning; 2013:256
- Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990;10:331–335
- Lee A, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): clinical features and diagnosis; 2010. Available from: http://www.uptodate.com [last accessed 12 Nov 2013]
- Miller NR. Papiledema. In: Miller NR, Newman NJ, eds. Walsh & Hoyt's clinical neuro-ophthalmology. 5th ed. Baltimore: Williams & Wilkins; 1998:487–548
- Lander CM. Minocycline-induced benign intracranial hypertension. Clin Exp Neurol 1989;26:161–167